Central nervous system non-Hodgkin's lymphoma is a rare form of neoplasia whose incidence has risen from 1% to 2-6% of cerebral tumours over the past five years.' We present a series of four cases acquired over three years. These comprised 6% of all tumours diagnosed by cerebrospinal fluid (CSF) cytology.
phenotypes were two T cell tumours, one B cell, and one null. A review of 13 previously recorded cases of immunocytologically diagnosed CNS nonHodgkin's lymphoma showed that there were 10 B cell, two T cell, and one null tumour. Overall (17 cases) the cell phenotype distribution was 65% B cell, 24% T cell, and 11% null. High CSF lymphocyte counts were found in 94%, proteinosis in 85%, and low CSF glucose in 87%.
In contrast to the B cell tumours, all of the T cell tumours were diagnosed by CSF cytology before being visualised radiologically. It is suggested that all CSF lymphocytes (>5 x 10'/ml) should be immunohistochemically typed to permit earlier diagnosis of CNS nonHodgkin's lymphoma.
Central nervous system non-Hodgkin's lymphoma is a rare form of neoplasia whose incidence has risen from 1% to 2-6% of cerebral tumours over the past five years.' We present a series of four cases acquired over three years. These comprised 6% of all tumours diagnosed by cerebrospinal fluid (CSF) cytology.
Case histories All the patients had been previously healthy and the clinical details of the four cases are summarised below. The antibodies used in the lymphoma panel were anti-Ig, anti-HLA-DR, anti-CD3, anti-CD5, anti-CD10, anti-CD19, anti-CD25, and anti-CD45. Two separate positive specimens were required for a diagnosis to be made.
Results
The CSF biochemical and cytological findings are shown in table 1. CSF biochemistry showed pronounced proteinosis (19-4-51-0 g/l; reference limit 10 g/l), and a reduced glucose concentration (0-2-1-9 mmnol/l; reference limits 45-6.5 CSF cytology is an unreliable investigation with a positive yield ranging from 3-44% of cases.34 Thirteen cases of CNS-non-Hodgkin's lymphoma diagnosed by CSF immunocytology have been described (table 2). 7 These comprise seven males, two females, and four unidentified cases with an average age of50 years (range 14-73). The four cases presented here raise the total number of reported cases2 to 17 of whom 14 (82%) had a grossly raised cell count, two (12%) had mild lymphocytosis, and only one had a cell count within normal limits. CSF proteinosis occurred in 12 (85%) cases in line with previous studies.4 CSF glucose was reduced in 87% (seven of eight) in whom the investigation had been performed.
Histological studies of CNS-non-Hodgkin's lymphoma have shown a morphological distribution of 53% immunoblastic, 20% noncleaved large cell, 20% cleaved large cell and 6% small cell, and have emphasised the B cell origin of this tumour.25 The four cases described here were large cell, of which one had a cleaved nuclear pattern. Overall, this changes the distribution of immunological subtypes in cytologically diagnosed CNS-non-Hodgkin's lympyhoma to 65% B cell (11 cases), 24% T cell (four cases), and 11% null (two cases). The four cases of T cell CNS-non-Hodgkin's lymphoma had no radiologically visible tumour deposits at the time of diagnosis. The clinical importance ofthis finding is unclear as few cases of T cell CNS-non-Hodgkin's lymphoma have been described.67
This study shows that cytological diagnosis of some lymphomas is possible before tumour deposits are detected radiologically. CSF cytology, however, is a specialised investigation and false positive results can occur with reactive processes, though the use of multiple sampling and immunohistochemical techniques increases the diagnostic reliability.7 We suggest that all unexplained persistent CSF lymphocytoses should be viewed as suspicious and that efforts should be made to immunotype the cells present as earlier diagnosis would improve the prognosis of primary cerebral lymphoma.
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Pathology
The resected specimen consisted of 40 cm of small intestine, the appendix, and 10 cm of large bowel with the associated mesentery. There was a fungating tumour sparing the terminal 5 cm of ileum but affecting the mucosa of the next 5 cm and spreading through the thickness of the wall into the mesentery. Focal areas of calcification were identified on cut section.
Paraffin wax sections showed the tumour to be a moderately differentiated keratinising squamous cell carcinoma arising from the surface epithelium. Intercellular bridges and keratinous cysts and pearls were prominent (figure). The tumour had infiltrated the wall and extended into the mesentery and paraintestinal lymph nodes. There was evidence of vascular invasion, but none of glandular differentiation or adenomatous change in any part of the tumour.
Mucin stains and Gremelius argyrophil stains were negative. Electron microscopical examination showed features typical of squamous cell differentiation. The neoplastic cells contained well formed tonofilaments, while microvilli, glycocalyceal bodies; mucinous granules were absent.
Discussion
The spread of tumour into the small bowel as a result of secondary squamous carcinoma has been well documented.'`Primary malignant tumours, however, are rare and the squamous carcinomas have so far been reported in cases of duplication.4
In the colon squamous cell differentiation is seen in about 0-05% of adenocarcinomata5 and in 0-4% of adenomata.6
The pathogenesis of squamous cell carcinoma of the colon is unknown but in some cases it has been associated with carcinoma
